K-Y WARMING LIQUID

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 04 report with the FDA on 2004-10-11 for K-Y WARMING LIQUID manufactured by Personal Products Co..

Event Text Entries

[311962] Consumer's spouse reported that 10 minutes after consumer used co's product they developed hives and itching all over, sweating, staggering, swelling of face, closing of throat and loss of consciousness for 10 minutes. Rescue squad was called. Two intravenous catheters were inserted, an electrocardiogram was done, oxygen was administered and epinerphrine was given twice. Consumer was hospitalized overnight and states their diagnosis was anaphylactic shock. This incident occurred during intercourse.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2214133-2004-00001
MDR Report Key548424
Report Source04
Date Received2004-10-11
Date of Report2004-10-11
Date of Event2004-05-01
Date Mfgr Received2004-09-13
Date Added to Maude2004-10-15
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location0
Manufacturer Street199 GRANDVIEW RD
Manufacturer CitySKILLMAN NJ 08558
Manufacturer CountryUS
Manufacturer Postal08558
Manufacturer Phone9089043708
Manufacturer G1*
Manufacturer Street*
Manufacturer City*
Manufacturer Country*
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameK-Y WARMING LIQUID
Generic NamePERSONAL LUBRICANT
Product CodeMMS
Date Received2004-10-11
Model NumberNA
Catalog NumberNA
Lot NumberUNK
ID NumberNA
OperatorLAY USER/PATIENT
Device AvailabilityN
Device Eval'ed by MfgrR
Implant FlagN
Date RemovedA
Device Sequence No1
Device Event Key537894
ManufacturerPERSONAL PRODUCTS CO.
Manufacturer Address199 GRANDVIEW RD. SKILLMAN NJ 08558 US


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization; 2. Life Threatening; 3. Required No Informationntervention 2004-10-11

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.